// App-Quantinova.ai

: Lysosome: At the Crossroads Between Na+-K+-ATPase and NLRP3 in Hyperuricemia-Induced Renal Tubular Injury

Researchers

Presenter

  • JingXiao

Principal Investigators

  • ZhibinYe

Medical Centers

  • Cancer Hospital Affiliated to Fudan University, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Tubular injury

Biomarkers

  • Cathepsin B

  • Interleukin 1 beta

  • NLR family pyrin domain containing 3

Drug/Treatment

  • Hydroxychloroquine

  • Febuxostat

  • Adenuric

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved